SHANGHAI & SAN FRANCISCO, Sept 12 (Bernama-BUSINESS WIRE) — Hansoh Pharmaceutical Group Company Limited (“Hansoh Pharma”), a leading biopharmaceutical company in China, and Atomwise, Inc. (“Atomwise”), the leader in artificial intelligence (AI) for drug discovery, have announced a collaboration to design and discover potential drug candidates for up to eleven undisclosed target proteins in multiple therapeutic areas.
- September 12, 2019
0
234
Less than a minute
You can share this post!
administrator
Related Articles
GTLF Evolves With Private Sector Support
- November 22, 2024
H2O.ai Unveils Agentic AI that Converges Generative and…
- November 22, 2024
New Fast ID Solution Expands Shufti Into Both…
- November 22, 2024